You might also like

Availability alert

More about Fast Facts: CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma

• Book details
• Synopsis
• Trending among others

Book synopsis

Diffuse large B-cell lymphoma (DLBCL) is the most common form of high-grade non-Hodgkin lymphoma. While treatment with immunochemotherapy has generally shown good outcomes, specific subgroups of patients with high-risk disease have an unfavorable prognosis. Extensive efforts have been made to improve outcomes in these patients. As such, CD19-targeted chimeric antigen receptor (CAR) T-cell therapy has become the new standard of care for patients with relapsed or refractory DLBCL after at least two prior lines of therapy. It is an exciting new therapeutic intervention that is integral to the concept of personalized medicine. Table of Contents: -DLBCL: an overview -CAR T cells -CAR T-cell products -Delivering CAR T-cell therapy and managing patient expectations -CAR T-cell therapy-related toxicities

Book details

Book category Books in English Medicine Clinical & internal medicine Haematology

• Full title: Fast Facts: CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma
• Subtitle: A practical resource for nurses
• Author: Richard J. Buka, Dee Moloney
• Language: English
• Binding: Paperback
• Number of pages: 94
• EAN: 9783318070248
• ID: 38506393
• Publisher: Karger
• Weight: 170 g
• Dimensions: 5 × 150 × 210 mm
• Date of publishing: 16. March 2022

Trending among others

---

---

---